Article
Molecular genetics of high-risk chronic lymphocytic leukemia.
Expert review of hematology - 1 Dec 2012
Rossi Davide, Gaidano Gianluca
Abstract excerpt
In an optimized management algorithm of chronic lymphocytic leukemia (CLL), the early identification of high-risk patients, ideally prior to treatment, is a prerequisite for designing strategies tailored at overcoming therapy resistance. TP53 abnormalities play a central role in our current understanding of the poor prognosis of high-risk CLL patients, but fail to explain the molecular basis of 50% of high-risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
